Cardinal Health CAH Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Cost of product sold | $12.64B+2.1% | $12.38B— | —— | $13.28B— | |
| Other Segments | $5.38B+19.3% | $4.51B— | —— | $3.52B— | |
| Pharmaceutical and Specialty Solutions | $204.64B-2.6% | $210.02B— | —— | $164.6B— | |
| Revenue by Geography | |||||
| Non-US | $1.67B-0.7% | $1.68B— | —— | —— | |
| UNITED STATES | $220.99B-1.9% | $225.23B+10.7% | $203.41B+13.3% | $179.47B+13.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cardinal Health break its business down?
- Cardinal Health (CAH) reports revenue by business across 3 parts — Cost of product sold, Other Segments and Pharmaceutical and Specialty Solutions. Each is extracted from the segment footnotes and tracked over time.
- Where does Cardinal Health's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cardinal Health's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
